Modelling the human coenzyme Q deficiency in Drosophila melanogaster

Area of Science:

• Biochemistry
• Genetics
• Mitochondrial Biology

Background:

• Coenzyme Q (CoQ) is essential for mitochondrial respiration and antioxidant defense.
• CoQ-dependent mitochondrial diseases in humans exhibit significant clinical heterogeneity.
• Drosophila melanogaster serves as a model organism to study complex biological pathways.

Purpose of the Study:

• To investigate the functional roles of genes in the CoQ biosynthesis pathway using Drosophila melanogaster.
• To understand the pathophysiology of CoQ deficiency by creating gene-specific knockdowns.
• To evaluate the therapeutic potential of CoQ10 supplementation in rescuing CoQ deficiency phenotypes.

Main Methods:

• Systematic knockdown of all CoQ biosynthesis genes in Drosophila at varying temperatures.
• Quantification of gene knockdown efficiency via Q-RTPCR and CoQ levels via HPLC-UV + ECD.
• Assessment of mitochondrial function, oxidative stress, mechanical stress resistance, and lifespan.
• Evaluation of CoQ10 supplementation for phenotype rescue.

Main Results:

• Knockdown of different CoQ biosynthesis genes resulted in gene-specific developmental defects and varied CoQ depletion levels.
• Specific gene knockdowns (e.g., coq7) led to accumulation of pathway intermediates, impaired mitochondrial complex assembly, and increased oxidative stress.
• Coq7 mutant flies exhibited developmental lethality, bang sensitivity, and reduced lifespan, all rescued by CoQ10 supplementation.
• Tissue-specific knockdowns in imaginal discs caused deformities, also mitigated by CoQ10.

Conclusions:

• The Drosophila CoQ biosynthesis pathway exhibits diverse phenotypes dependent on the targeted gene, mirroring human CoQ deficiency syndromes.
• This model highlights the complexity of CoQ deficiency and explains why certain gene mutations are rare in patients.
• CoQ10 supplementation is a promising therapeutic strategy for CoQ deficiency disorders.